Publication identifier(s): 20457606
Bidirectional lipid inositolphosphotransferase (experimentally validated). Homologous to animal phosphatidylcholine:ceramide cholinephosphotransferases. Expanded on the Trypanosoma lineage.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005768 | endosome | 7 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0020016 | ciliary pocket | 2 | 1 |
GO:0031410 | cytoplasmic vesicle | 6 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: A4IC70
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 16 |
GO:0006665 | sphingolipid metabolic process | 4 | 16 |
GO:0006793 | phosphorus metabolic process | 3 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016310 | phosphorylation | 5 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044255 | cellular lipid metabolic process | 3 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
GO:0006066 | alcohol metabolic process | 3 | 1 |
GO:0006576 | biogenic amine metabolic process | 5 | 1 |
GO:0006580 | ethanolamine metabolic process | 5 | 1 |
GO:0006672 | ceramide metabolic process | 4 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009308 | amine metabolic process | 4 | 1 |
GO:0009309 | amine biosynthetic process | 5 | 1 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 1 |
GO:0034308 | primary alcohol metabolic process | 4 | 1 |
GO:0034309 | primary alcohol biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042401 | biogenic amine biosynthetic process | 6 | 1 |
GO:0042439 | ethanolamine-containing compound metabolic process | 4 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046165 | alcohol biosynthetic process | 4 | 1 |
GO:0046335 | ethanolamine biosynthetic process | 6 | 1 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 1 |
GO:0046513 | ceramide biosynthetic process | 5 | 1 |
GO:1901160 | primary amino compound metabolic process | 4 | 1 |
GO:1901162 | primary amino compound biosynthetic process | 5 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0016301 | kinase activity | 4 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 16 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 16 |
GO:0033188 | sphingomyelin synthase activity | 5 | 6 |
GO:0047493 | ceramide cholinephosphotransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 328 | 332 | PF00656 | 0.714 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.387 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.259 |
CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.400 |
DEG_APCC_DBOX_1 | 35 | 43 | PF00400 | 0.323 |
DOC_CKS1_1 | 322 | 327 | PF01111 | 0.704 |
DOC_MAPK_DCC_7 | 109 | 119 | PF00069 | 0.530 |
DOC_MAPK_DCC_7 | 63 | 73 | PF00069 | 0.310 |
DOC_MAPK_gen_1 | 63 | 73 | PF00069 | 0.290 |
DOC_MAPK_MEF2A_6 | 36 | 45 | PF00069 | 0.296 |
DOC_MAPK_MEF2A_6 | 64 | 73 | PF00069 | 0.305 |
DOC_MAPK_NFAT4_5 | 36 | 44 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 130 | 136 | PF00149 | 0.589 |
DOC_PP4_FxxP_1 | 237 | 240 | PF00568 | 0.545 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.289 |
DOC_USP7_MATH_1 | 326 | 330 | PF00917 | 0.656 |
DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.428 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.704 |
DOC_WW_Pin1_4 | 358 | 363 | PF00397 | 0.745 |
DOC_WW_Pin1_4 | 366 | 371 | PF00397 | 0.707 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.287 |
LIG_14-3-3_CanoR_1 | 244 | 253 | PF00244 | 0.311 |
LIG_14-3-3_CanoR_1 | 262 | 271 | PF00244 | 0.163 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.585 |
LIG_BRCT_BRCA1_1 | 224 | 228 | PF00533 | 0.361 |
LIG_eIF4E_1 | 265 | 271 | PF01652 | 0.242 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.633 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.619 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.413 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.289 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.236 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.287 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.753 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.403 |
LIG_FHA_2 | 322 | 328 | PF00498 | 0.726 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.666 |
LIG_FHA_2 | 78 | 84 | PF00498 | 0.389 |
LIG_IRF3_LxIS_1 | 247 | 254 | PF10401 | 0.358 |
LIG_LIR_Apic_2 | 235 | 240 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 160 | 168 | PF02991 | 0.323 |
LIG_LIR_Gen_1 | 170 | 179 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 254 | 260 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 233 | 237 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 279 | 283 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.356 |
LIG_MYND_1 | 236 | 240 | PF01753 | 0.537 |
LIG_NRBOX | 38 | 44 | PF00104 | 0.432 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.402 |
LIG_Pex14_2 | 237 | 241 | PF04695 | 0.518 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.306 |
LIG_SH2_CRK | 24 | 28 | PF00017 | 0.573 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.306 |
LIG_SH2_PTP2 | 274 | 277 | PF00017 | 0.439 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.306 |
LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.236 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.221 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.228 |
LIG_SH3_3 | 118 | 124 | PF00018 | 0.534 |
LIG_SH3_3 | 319 | 325 | PF00018 | 0.703 |
LIG_SUMO_SIM_anti_2 | 316 | 324 | PF11976 | 0.710 |
LIG_SUMO_SIM_par_1 | 198 | 204 | PF11976 | 0.293 |
LIG_SUMO_SIM_par_1 | 316 | 324 | PF11976 | 0.671 |
LIG_SUMO_SIM_par_1 | 38 | 44 | PF11976 | 0.378 |
LIG_TRAF2_1 | 308 | 311 | PF00917 | 0.673 |
LIG_TRAF2_1 | 314 | 317 | PF00917 | 0.711 |
LIG_TYR_ITIM | 253 | 258 | PF00017 | 0.361 |
LIG_TYR_ITSM | 158 | 165 | PF00017 | 0.402 |
LIG_UBA3_1 | 72 | 78 | PF00899 | 0.390 |
LIG_WRC_WIRS_1 | 126 | 131 | PF05994 | 0.599 |
LIG_WRC_WIRS_1 | 168 | 173 | PF05994 | 0.225 |
MOD_CDK_SPxxK_3 | 358 | 365 | PF00069 | 0.606 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.287 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.279 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.665 |
MOD_CK1_1 | 356 | 362 | PF00069 | 0.745 |
MOD_CK2_1 | 321 | 327 | PF00069 | 0.604 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.284 |
MOD_CMANNOS | 300 | 303 | PF00535 | 0.417 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.397 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.381 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.549 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.197 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.225 |
MOD_GlcNHglycan | 331 | 335 | PF01048 | 0.538 |
MOD_GlcNHglycan | 358 | 361 | PF01048 | 0.528 |
MOD_GlcNHglycan | 376 | 379 | PF01048 | 0.428 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.329 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.272 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.728 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.738 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.522 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.395 |
MOD_N-GLC_2 | 183 | 185 | PF02516 | 0.553 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.288 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.289 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.287 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.287 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.386 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.353 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.392 |
MOD_NEK2_2 | 152 | 157 | PF00069 | 0.392 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.467 |
MOD_PKA_2 | 379 | 385 | PF00069 | 0.639 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.428 |
MOD_Plk_2-3 | 368 | 374 | PF00069 | 0.569 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.611 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.521 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.299 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.306 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.312 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.377 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.262 |
MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.428 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.706 |
MOD_ProDKin_1 | 358 | 364 | PF00069 | 0.747 |
MOD_ProDKin_1 | 366 | 372 | PF00069 | 0.708 |
TRG_DiLeu_BaLyEn_6 | 359 | 364 | PF01217 | 0.606 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.299 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.436 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.209 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.296 |
TRG_ER_diArg_1 | 142 | 144 | PF00400 | 0.605 |
TRG_NLS_MonoExtC_3 | 62 | 67 | PF00514 | 0.267 |
TRG_NLS_MonoExtN_4 | 60 | 67 | PF00514 | 0.262 |
TRG_Pf-PMV_PEXEL_1 | 66 | 70 | PF00026 | 0.542 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRL7 | Leptomonas seymouri | 68% | 100% |
A0A0S4J1W3 | Bodo saltans | 41% | 100% |
A0A1X0P4U9 | Trypanosomatidae | 45% | 100% |
A0A3S7XA07 | Leishmania donovani | 99% | 100% |
A0A422NCN9 | Trypanosoma rangeli | 44% | 100% |
A4HNG1 | Leishmania braziliensis | 68% | 100% |
B3A0L9 | Trypanosoma brucei brucei | 41% | 100% |
B3A0M0 | Trypanosoma brucei brucei | 41% | 100% |
B3A0M1 | Trypanosoma brucei brucei | 43% | 100% |
B3A0M2 | Trypanosoma brucei brucei | 43% | 100% |
C9ZYF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZYF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYF9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYG0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYG2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AFX2 | Leishmania major | 93% | 100% |
E9B725 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 99% |
Q38E53 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 42% | 100% |
Q38E54 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 42% | 100% |
Q38E55 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 44% | 100% |
Q38E56 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 43% | 100% |
Q4E4I4 | Trypanosoma cruzi (strain CL Brener) | 52% | 100% |
Q7T3T4 | Gallus gallus | 25% | 92% |
Q96LT4 | Homo sapiens | 24% | 93% |
Q9DA37 | Mus musculus | 24% | 81% |